Trimethylamine N-oxide (TMAO) for risk stratification after acute ischemic stroke: Results from the BIOSIGNAL cohort study.

Saved in:
Bibliographic Details
Title: Trimethylamine N-oxide (TMAO) for risk stratification after acute ischemic stroke: Results from the BIOSIGNAL cohort study.
Authors: Frenger J; Department of Neurology & Stroke Center, University Hospital of Basel & University of Basel, Basel, Switzerland., Jeker B; Department of Neurology & Stroke Center, University Hospital of Basel & University of Basel, Basel, Switzerland., Arnold M; Department of Neurology & Stroke Center, University Hospital of Basel & University of Basel, Basel, Switzerland., Grosse GM; Department of Neurology & Stroke Center, University Hospital of Basel & University of Basel, Basel, Switzerland., Pokorny T; Department of Neurology & Stroke Center, University Hospital of Basel & University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital Zurich, Zurich, Switzerland., Westphal LP; Department of Neurology, University Hospital Zurich, Zurich, Switzerland., Inauen C; Department of Neurology, University Hospital Zurich, Zurich, Switzerland., Bicciato G; Department of Neurology, University Hospital Zurich, Zurich, Switzerland., Arnold M; Department of Neurology, University Hospital and University of Bern, Bern, Switzerland., Fischer U; Department of Neurology, University Hospital and University of Bern, Bern, Switzerland., De Marchis GM; Department of Neurology & Stroke Center, University Hospital of Basel & University of Basel, Basel, Switzerland.; Department of Neurology & Stroke Center, Cantonal Hospital St. Gallen, University Teaching and Research Hospital, St. Gallen, Switzerland., Kägi G; Department of Neurology, University Hospital and University of Bern, Bern, Switzerland.; Department of Neurology & Stroke Center, Cantonal Hospital St. Gallen, University Teaching and Research Hospital, St. Gallen, Switzerland., Kahles T; Department of Neurology, Cantonal Hospital Aarau, Aarau, Switzerland., Cereda CW; Neurocentro della Svizzera Italiana, Stroke Center EOC, Lugano, Switzerland., Bustamante A; Stroke Unit, Department of Neurology, Hospital Universitari Germans Trias i Pujol, Germans Trias i Pujol Research Institute (IGTP), Barcelona, Spain., Montaner J; Institute de Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC/University of Seville, Seville, Spain.; Department of Neurology, Hospital Universitario Virgen Macarena, Seville, Spain., Ntaios G; Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece., Foerch C; Department of Neurology, RKH Hospital Ludwigsburg, Ludwigsburg, Germany., Spanaus K; Institute of Clinical Chemistry, University Hospital Zurich, Zurich, Switzerland., von Eckardstein A; Institute of Clinical Chemistry, University Hospital Zurich, Zurich, Switzerland., Mueller D; Institute of Clinical Chemistry, University Hospital Zurich, Zurich, Switzerland.; Department of Clinical Chemistry, University Hospital of Basel & University of Basel, Basel, Switzerland.; Department of Chemistry, Solothurn Hospitals AG, Solothurn, Switzerland., Katan M; Department of Neurology & Stroke Center, University Hospital of Basel & University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital Zurich, Zurich, Switzerland.
Source: European stroke journal [Eur Stroke J] 2026 Jan 01; Vol. 11 (1).
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: SAGE Publications Ltd Country of Publication: England NLM ID: 101688446 Publication Model: Print Cited Medium: Internet ISSN: 2396-9881 (Electronic) Linking ISSN: 23969873 NLM ISO Abbreviation: Eur Stroke J Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2396-9881
DOI:10.1093/esj/23969873251366192